# Omega-3 PUFA for Treatment of Patients With Idiopathic Oligoasthenoteratospermia

> **NCT03634644** · PHASE1 · UNKNOWN · sponsor: **Jinling Hospital, China** · enrollment: 30 (estimated)

## Conditions studied

- Male Infertility Due to Hypospermatogenesis

## Interventions

- **DRUG:** Omega 3 fatty acid
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03634644
- **Lead sponsor:** Jinling Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-08
- **Primary completion:** 2019-03-17
- **Final completion:** 2022-10-28
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03634644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03634644, "Omega-3 PUFA for Treatment of Patients With Idiopathic Oligoasthenoteratospermia". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03634644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*